In their monthly Law360 column on recent noteworthy Federal Circuit rulings, partners Jeremiah Helm and Sean Murray explore the Federal Circuit’s decision in Shockwave Medical v. Cardiovascular Systems. The Federal…

Knobbe Martens partners Irfan Lateef and Ted Cannon co-authored “Recent Developments in Intellectual Property Law 2025,” a chapter in the ABA Business and Corporate Law Section’s “Recent Developments in Business…

The U.S. Patent Office’s program for expedited examination of design applications under 37 CFR 1.155 (often called the design “rocket docket”), which was suspended earlier this year, was formally canceled…

In the AdAge article “How Brands Can Avoid Risk When Bidding on Competitor Trademarks as Search Keywords,” lawyers Jonathan Menkes and Zachary Greenberg explore the complex legal landscape of digital…

In the latest installment of their Law360 column on recent noteworthy Federal Circuit decisions, partners Sean Murray and Jeremiah Helm examined the outcome in Eye Therapies LLC v. Slayback Pharma…

With the release of ChatGPT in late 2022, generative AI entered the cultural zeitgeist. Not surprisingly, within a few months, the first generative AI lawsuits were filed in the U.S….

In the latest edition of their Law360 column on noteworthy Federal Circuit rulings, partners Jeremiah Helm and Sean Murray examine the recent decision in In re: Thomas D. Foster APC. In this ruling, the Federal…

In the Bloomberg Law article “Growing Denials of PTAB Petitions Demand Sharp Patent Strategies”, Knobbe Martens partner Ted Cannon explored the increase in denials of Patent Trial and Appeal Board…

On June 18, 2025, the United States Patent and Trademark Office (USPTO) hosted an informational call to share the results of a study on the Deferred Subject Matter Eligibility (DSMER)…

The rules regarding specimens (evidence of trademark use)[1] assess whether a trademark applicant is using the mark in a manner that engenders trademark rights.[2]  Accordingly, specimens must support the facts…